Floatz logo

Ethiodized Oil

Neoplastic Cells, Circulating

Fudan UniversityPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Neoplastic Cells, Circulating cohort.

Asset / SponsorPhaseRating
Theprubicin
Fudan University
Phase 4BB
Inno-206
Fudan University
Phase 4BB
Epirubicin
Fudan University
Phase 4B

Same molecule, other indications

Ethiodized Oil is also rated in:

hepatocellular carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
Colon Cancer Liver MetastasisDormant
BB
Indicative ·
66 / 100
View asset →
Transarterial ChemoembolizationDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →